ArticleThe oncologist2025

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population.

Federica Lo Prinzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.